Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Management Change

Arvee Laboratories announced the resignation of Raina Singh as Company Secretary and Compliance Officer, effective September 9, 2026.

Arvee Laboratories (India) Q1 FY27 Results: Net Profit ₹1.7 Cr, Up 750.0% YoY

Arvee Laboratories (India) Ltd reported revenue from operations of ₹17.2 Cr (+129.3% YoY) and net profit of ₹1.7 Cr (+750.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.7 Cr · +750.0% YoY

Arvee Laboratories (India) Board Meeting Date

Arvee Laboratories (India) Limited has scheduled a board meeting for August 7, 2026. The agenda includes reviewing quarterly standalone unaudited financial results and a scheme of arrangement.

Arvee Laboratories (India) Board Meeting Date

Arvee Laboratories (India) Limited has scheduled a Board Meeting for May 18, 2026, to approve the audited standalone financial results for the year ended March 2026. The company also confirmed that the trading window for designated persons has been closed since April 1, 2026.

Arvee Laboratories (India) Board Meeting Date

Arvee Laboratories (India) Limited has scheduled a board meeting on May 18, 2026, to consider and approve the audited standalone financial results for the year ended March 31, 2026. The trading window for designated persons remains closed until May 20, 2026.

Arvee Laboratories (India) Price Movement Clarification

Arvee Laboratories (India) Limited clarified to NSE that there are no undisclosed material events affecting its share price. The company confirmed compliance with SEBI Listing Regulations, stating price movement is solely determined by market forces and shareholders. No internal developments require disclosure at this time.

Arvee Laboratories (India) Q3 FY26 Results: Net Profit ₹1.8 Cr, Up 800.0% YoY

Arvee Laboratories (India) Ltd reported net profit of ₹1.8 Cr (+800.0% YoY) for Q3 FY26.

Key figure

Net profit ₹1.8 Cr · +800.0% YoY